Vision 2030 is the key catalyst for money making opportunities in Saudi Arabia.
The shear amount of change happening all at once is impressive. What is it this time?
Essentially the kingdom aims to increase private sector healthcare and reduce the public sector supply.
This shift in the healthcare policy will cause enormous profits for well positioned companies.
And we, as your Drill Buddies have found the best positioned stock!
📈The Stock: Al Hammadi (4007.SR)
They invest in hospitals and healthcare within Riyadh, the capital:
2 Large Hospitals → 600 Beds and 220 Clinics
Building 2 More Hospitals → Scheduled for 2026 and 2028
Vertically Integrated → Owns Sudair Pharmaceutical
In short: They keep the wealthiest city, healthy
💰Show me The Money
As of 2025, Al Hammadi has great fundamentals and is an attractive buy!
Operating Cash Flow (SAR) | 365.7 M |
Net Profit (SAR) | 339.0 M |
Return on Equity (%) | 18.19 |
Debt/Equity (%) | 15.5 |
Revenue is split between hospitals (82%) and pharmaceutical sales (18%). Most patients pay through private health insurance, which is mandatory in Saudi Arabia.
Looking ahead, profitability is expected to rise as two new hospitals come online and debt levels decline.
The thesis is simple:
More demand for healthcare × Higher pricing power = Higher margins.
To top it off, the company currently offers a 3.64% dividend yield.
This isn’t the sexiest industry, but guess what? It works, and if it works it makes money….
See You Next Sunday!